"Anders is a mentor and role model. His resignation will not mean a disconitation of our close relationship we have built up over the years. I look forward to continuing to seek his advice even after he has left his official role in the Company," says CEO Mathias Svahn.

Prior to Anders' departure, the board has actively started working on identifying a suitable replacement and has assigned the nomination committee, together with NextCell's management team, the task of presenting candidates for the position of chairman before the annual general meeting on November 28, 2024. During this transition period, Hans-Peter Ekre, one of NextCell's board members, will and co-founder, to act as acting chairman of the board until the board is full and a new regular chairman can be appointed.

"NextCell looks forward to an exciting future with continued growth, while we thank Anders for his contribution and wish him the best", says Hans-Peter Ekre. "During the spring and summer, we will intensify contacts with attractive partners for T1D and also with distributors for the resale of stem and immunomodulating cells."